Synthesis 2012; 44(17): 2779-2785
DOI: 10.1055/s-0032-1316643
paper
© Georg Thieme Verlag Stuttgart · New York

A Synthesis of the Pseudopterosin A–F Aglycone

John P. Cooksey*
School of Chemistry and Institute of Process Research and Development, University of Leeds, Leeds LS2 9JT, UK, Fax: +44(113)3436401   Email: p.j.kocienski@leeds.ac.uk   Email: j.p.cooksey@leeds.ac.uk
,
Philip J. Kocieński*
School of Chemistry and Institute of Process Research and Development, University of Leeds, Leeds LS2 9JT, UK, Fax: +44(113)3436401   Email: p.j.kocienski@leeds.ac.uk   Email: j.p.cooksey@leeds.ac.uk
,
Arndt W. Schmidt
School of Chemistry and Institute of Process Research and Development, University of Leeds, Leeds LS2 9JT, UK, Fax: +44(113)3436401   Email: p.j.kocienski@leeds.ac.uk   Email: j.p.cooksey@leeds.ac.uk
,
Thomas N. Snaddon
School of Chemistry and Institute of Process Research and Development, University of Leeds, Leeds LS2 9JT, UK, Fax: +44(113)3436401   Email: p.j.kocienski@leeds.ac.uk   Email: j.p.cooksey@leeds.ac.uk
,
Colin A. Kilner
School of Chemistry and Institute of Process Research and Development, University of Leeds, Leeds LS2 9JT, UK, Fax: +44(113)3436401   Email: p.j.kocienski@leeds.ac.uk   Email: j.p.cooksey@leeds.ac.uk
› Author Affiliations
Further Information

Publication History

Received: 24 April 2012

Accepted: 13 June 2012

Publication Date:
08 August 2012 (online)


Abstract

The synthesis of the pseudopterosin A–F aglycone from 3-methylcatechol features (a) the use of asymmetric Ireland–Claisen and aryl Claisen rearrangements to install three of the four stereocentres present in the molecule and (b) an A→AB→ABC annulation strategy using ring-closing metathesis and cationic cyclisation reactions as the key steps.

Supporting Information

Primary Data

 
  • References

    • 1a Look SA, Fenical W, Jacobs RS, Clardy J. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 6238
    • 1b Look SA, Fenical W, Matsumoto GK, Clardy J. J. Org. Chem. 1986; 51: 5140
    • 2a Berrue F, Kerr RG. Nat. Prod. Rep. 2009; 26: 681
    • 2b Rodríguez AD. Tetrahedron 1995; 51: 4571
    • 3a Ata A, Win HY, Holt D, Holloway P, Segstro EP, Jayatilake GS. Helv. Chim. Acta 2004; 87: 1090
    • 3b Rodríguez II, Shi Y.-P, García OJ, Rodríguez AD, Mayer AM. S, Sánchez JA, Ortega-Barria E, González J. J. Nat. Prod. 2004; 67: 1672
    • 3c Ettouati WS, Jacobs RS. Mol. Pharmacol. 1987; 31: 500
    • 3d Correa H, Aristizabal F, Duque C, Kerr R. Marine Drugs 2011; 9: 334
    • 4a Roussis V, Wu Z, Fenical W, Strobel SA, Van D GD, Clardy J. J. Org. Chem. 1990; 55: 4916
    • 4b Mayer AM. S, Jacobson PB, Fenical W, Jacobs RS, Glaser KB. Life Sci. 1998; 62: PL401
    • 4c Ata A, Kerr RG, Moya CE, Jacobs RS. Tetrahedron 2003; 59: 4215
    • 4d Moya CE, Jacobs RS. Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 2006; 143: 436
    • 4e Correa H, Valenzuela AL, Ospina LF, Duque C. J. Inflamm. (London) 2009; 6: 5
    • 4f Dayan N, Grove G, Sivalenka R. IFSCC Mag. 2009; 12: 17
    • 5a Coleman AC, Kerr RG. Tetrahedron 2000; 56: 9569
    • 5b Hoarau C, Day D, Moya C, Wu G, Hackim A, Jacobs RS, Little RD. Tetrahedron Lett. 2008; 49: 4604
    • 6a Zhong W, Little RD. Tetrahedron 2009; 65: 10784
    • 6b Zhong W, Moya C, Jacobs RS, Little RD. J. Org. Chem. 2008; 73: 7011

      See for example:
    • 7a Fenical WH, Jacobs RS. US 5,624,911, 1997
    • 7b Haimes HH, Jimenez PA. US 5,597,808, 1997
    • 7c Jacobs RS, Kerr RG. US 7,060,686, 2006
    • 7d Jacobs RS, Mydlarz LD, Moya C. US 2005/0026897, 2005
    • 8a Broka CA, Chan S, Peterson B. J. Org. Chem. 1988; 53: 1584
    • 8b Corey EJ, Carpino P. J. Am. Chem. Soc. 1989; 111: 5472
    • 9a Ganguly AK, McCombie SW, Cox B, Lin S, McPhail AT. Pure Appl. Chem. 1990; 62: 1289
    • 9b McCombie SW, Cox B, Ganguly AK. Tetrahedron Lett. 1991; 32: 2087
    • 9c Buszek KR, Bixby DL. Tetrahedron Lett. 1995; 36: 9129
    • 9d Gill S, Kocieński P, Kohler A, Pontiroli A, Qun L. Chem. Commun. 1996; 1743
    • 9e Majdalani A, Schmalz HG. Synlett 1997; 1303
    • 9f Corey EJ, Lazerwith SE. J. Am. Chem. Soc. 1998; 120: 12777
    • 9g LeBrazidec J.-Y, Kocieński PJ, Connolly JD, Muir KW. J. Chem. Soc., Perkin Trans. 1 1998; 2475
    • 9h Chow R, Kocieński PJ, Kuhl A, LeBrazidec J.-Y, Muir K, Fish P. J. Chem. Soc., Perkin Trans. 1 2001; 2344
    • 9i Kocieński PJ, Pontiroli A, Qun L. J. Chem. Soc., Perkin Trans. 1 2001; 2356
    • 9j Harrowven DC, Tyte MJ. Tetrahedron Lett. 2004; 45: 2089
    • 9k Mans DJ, Cox GA, RajanBabu TV. J. Am. Chem. Soc. 2011; 133: 5776
    • 10a Corey EJ, Carpino P. Tetrahedron Lett. 1990; 31: 3857
    • 10b Kozikowski AP, Wu JP. Synlett 1991; 465
    • 10c Jung ME, Siedem CS. J. Am. Chem. Soc. 1993; 115: 3822
    • 10d McCombie SW, Ortiz C, Cox B, Ganguly AK. Synlett 1993; 541
    • 10e Harrowven DC, Dennison ST, Howes P. Tetrahedron Lett. 1994; 35: 4243
    • 10f Schmalz H.-G, Schwarz A, Dürner G. Tetrahedron Lett. 1994; 35: 6861
    • 10g Schmalz H.-G, Majdalani A, Geller T, Hollander J, Bats JW. Tetrahedron Lett. 1995; 36: 4777
    • 10h Eklund L, Sarvary I, Frejd T. J. Chem. Soc., Perkin Trans. 1 1996; 303
    • 10i Schmalz H.-G, Siegel S, Schwarz A. Tetrahedron Lett. 1996; 37: 2947
    • 10j Harrowven DC, Sibley GE. M. Tetrahedron Lett. 1999; 40: 8299
    • 10k Benoit-Marquie F, Csaky AG, Esteban G, Martinez ME, Plumet J. Tetrahedron Lett. 2000; 41: 3355
    • 10l Jung ME, Lee BS. J. Org. Chem. 2000; 65: 9241
    • 10m Harrowven DC, Wilden JD, Tyte MJ, Hursthouse MB, Coles SJ. Tetrahedron Lett. 2001; 42: 1193
    • 10n Esteban G, Rincon R, Csaky AG, Plumet J. Nat. Prod. Commun. 2008; 3: 495
    • 11a Trost BM, Ghadiri MR. J. Am. Chem. Soc. 1984; 106: 7260
    • 11b Trost BM, Ghadiri MR. J. Am. Chem. Soc. 1986; 108: 1098
  • 12 Corey EJ, Lee DH. J. Am. Chem. Soc. 1991; 113: 4026
  • 13 Majumdar KC, Alam S, Chattopadhyay B. Tetrahedron 2008; 64: 597
  • 14 Chan C, Heid R, Zheng S, Guo J, Zhou B, Furuuchi T, Danishefsky SJ. J. Am. Chem. Soc. 2005; 127: 4596
  • 15 The choice of protecting group for the C10 hydroxyl group was important. The methoxymethyl, benzyloxymethyl and methanesulfonyl derivatives of compound 11 proved to be incompatible with the reaction conditions used in the subsequent Ireland–Claisen rearrangement.
  • 16 Pan D, Chen A, Su Y, Zhou W, Li S, Jia W, Xiao J, Liu Q, Zhang L, Jiao N. Angew. Chem. Int. Ed. 2008; 47: 4729
  • 17 Jeffery T. Tetrahedron Lett. 1991; 32: 2121
  • 18 Corey EJ, Kim SS. J. Am. Chem. Soc. 1990; 112: 4976
  • 19 Churcher I, Williams S, Kerrad S, Harrison T, Castro JL, Shearman MS, Lewis HD, Clarke EE, Wrigley JD. J, Beher D, Tang YS, Liu W. J. Med. Chem. 2003; 46: 2275
  • 20 Bower JF, Szeto P, Gallagher T. Org. Biomol. Chem. 2007; 5: 143
  • 21 Dale JA, Mosher HS. J. Am. Chem. Soc. 1973; 95: 512
  • 22 Ito H, Sato A, Taguchi T. Tetrahedron Lett. 1997; 38: 4815
  • 23 Trost BM, Crawley ML. Chem. Rev. 2003; 103: 2921
  • 24 Trost BM, Toste FD. J. Am. Chem. Soc. 1998; 120: 815
  • 25 Ramadhar TR, Kawakami J.-i, Lough AJ, Batey RA. Org. Lett. 2010; 12: 4446
  • 26 Fürstner A. Angew. Chem. Int. Ed. 2000; 39: 3012
  • 27 Scholl M, Ding S, Lee CW, Grubbs RH. Org. Lett. 1999; 1: 953
  • 28 Kuhn KM, Champagne TM, Hong SH, Wei W.-H, Nickel A, Lee CW, Virgil SC, Grubbs RH, Pederson RL. Org. Lett. 2010; 12: 984
  • 29 Hong SH, Sanders DP, Lee CW, Grubbs RH. J. Am. Chem. Soc. 2005; 127: 17160
  • 30 Trnka TM, Grubbs RH. Acc. Chem. Res. 2000; 34: 18
  • 31 Garber SB, Kingsbury JS, Gray BL, Hoveyda AH. J. Am. Chem. Soc. 2000; 122: 8168
  • 32 An extract of P. elisabethae rich in pseudopterosins is a component of Resilience™, a skin care product of Estée Lauder that reduces skin inflammation from sunburn or irritation, see: Rouhi AM. Chem. Eng. News 1995; 73 (47): 42
  • 33 Mydlarz LD, Jacobs RS, Boehnlein J, Kerr RG. Chem. Biol. 2003; 10: 1051
  • 34 Bunyajetpong S, Santiago-Vazquez LZ, Kerr R. US 2009/0269071, 2009